Suppr超能文献

可注射的自组装肽纳米纤维为内皮细胞创造心肌内微环境。

Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells.

作者信息

Davis Michael E, Motion J P Michael, Narmoneva Daria A, Takahashi Tomosaburo, Hakuno Daihiko, Kamm Roger D, Zhang Shuguang, Lee Richard T

机构信息

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

出版信息

Circulation. 2005 Feb 1;111(4):442-50. doi: 10.1161/01.CIR.0000153847.47301.80.

Abstract

BACKGROUND

Promoting survival of transplanted cells or endogenous precursors is an important goal. We hypothesized that a novel approach to promote vascularization would be to create injectable microenvironments within the myocardium that recruit endothelial cells and promote their survival and organization.

METHODS AND RESULTS

In this study we demonstrate that self-assembling peptides can be injected and that the resulting nanofiber microenvironments are readily detectable within the myocardium. Furthermore, the self-assembling peptide nanofiber microenvironments recruit progenitor cells that express endothelial markers, as determined by staining with isolectin and for the endothelial-specific protein platelet-endothelial cell adhesion molecule-1. Vascular smooth muscle cells are recruited to the microenvironment and appear to form functional vascular structures. After the endothelial cell population, cells that express alpha-sarcomeric actin and the transcription factor Nkx2.5 infiltrate the peptide microenvironment. When exogenous donor green fluorescent protein-positive neonatal cardiomyocytes were injected with the self-assembling peptides, transplanted cardiomyocytes in the peptide microenvironment survived and also augmented endogenous cell recruitment.

CONCLUSIONS

These experiments demonstrate that self-assembling peptides can create nanofiber microenvironments in the myocardium and that these microenvironments promote vascular cell recruitment. Because these peptide nanofibers may be modified in a variety of ways, this approach may enable injectable tissue regeneration strategies.

摘要

背景

促进移植细胞或内源性前体细胞的存活是一个重要目标。我们推测,一种促进血管生成的新方法是在心肌内创建可注射的微环境,以募集内皮细胞并促进其存活和组织化。

方法与结果

在本研究中,我们证明自组装肽可以注射,并且在心肌内很容易检测到由此产生的纳米纤维微环境。此外,通过异凝集素染色和检测内皮特异性蛋白血小板内皮细胞黏附分子-1,确定自组装肽纳米纤维微环境募集了表达内皮标志物的祖细胞。血管平滑肌细胞被募集到微环境中,并似乎形成功能性血管结构。在内皮细胞群体之后,表达α-肌节肌动蛋白和转录因子Nkx2.5的细胞浸润肽微环境。当将外源性供体绿色荧光蛋白阳性新生心肌细胞与自组装肽一起注射时,肽微环境中的移植心肌细胞存活,并且还增强了内源性细胞募集。

结论

这些实验表明,自组装肽可以在心肌内创建纳米纤维微环境,并且这些微环境促进血管细胞募集。由于这些肽纳米纤维可以通过多种方式进行修饰,这种方法可能实现可注射的组织再生策略。

相似文献

1
Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells.
Circulation. 2005 Feb 1;111(4):442-50. doi: 10.1161/01.CIR.0000153847.47301.80.
3
Transplanted adult bone marrow cells repair myocardial infarcts in mice.
Ann N Y Acad Sci. 2001 Jun;938:221-9; discussion 229-30. doi: 10.1111/j.1749-6632.2001.tb03592.x.
5
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts.
J Mol Cell Cardiol. 2007 Oct;43(4):504-16. doi: 10.1016/j.yjmcc.2007.07.001. Epub 2007 Jul 14.
6
Delivery of Stem Cells and BMP-2 With Functionalized Self-Assembling Peptide Enhances Regeneration of Infarcted Myocardium.
Stem Cell Rev Rep. 2024 Aug;20(6):1540-1554. doi: 10.1007/s12015-024-10721-7. Epub 2024 Apr 24.
7
Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.
Stem Cells Transl Med. 2016 Feb;5(2):141-51. doi: 10.5966/sctm.2015-0083. Epub 2015 Dec 18.
9
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
Circ Res. 2005 Jan 7;96(1):127-37. doi: 10.1161/01.RES.0000151843.79801.60. Epub 2004 Nov 29.
10
Generation of Cardiomyocytes From Vascular Adventitia-Resident Stem Cells.
Circ Res. 2018 Aug 31;123(6):686-699. doi: 10.1161/CIRCRESAHA.117.312526.

引用本文的文献

1
Immunomodulatory Delivery Materials for Tissue Repair.
Adv Healthc Mater. 2025 Jun 29:e2501400. doi: 10.1002/adhm.202501400.
3
Exploring hiPSC-CM replacement therapy in ischemic hearts.
Basic Res Cardiol. 2025 Jun 10. doi: 10.1007/s00395-025-01117-w.
4
Rat Sarcoma (RAS)-Protein-Targeting Synthetic Cell-Penetrating Peptide as an Anticancer Biomaterial.
Biomater Res. 2025 Apr 15;29:0175. doi: 10.34133/bmr.0175. eCollection 2025.
5
Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
Circulation. 2024 Jun 18;149(25):2002-2020. doi: 10.1161/CIRCULATIONAHA.123.067097. Epub 2024 Jun 17.
6
Delivery of Stem Cells and BMP-2 With Functionalized Self-Assembling Peptide Enhances Regeneration of Infarcted Myocardium.
Stem Cell Rev Rep. 2024 Aug;20(6):1540-1554. doi: 10.1007/s12015-024-10721-7. Epub 2024 Apr 24.
7
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.
10
Characterization of the Monocyte Response to Biomaterial Therapy for Cardiac Repair.
Methods Mol Biol. 2022;2485:279-298. doi: 10.1007/978-1-0716-2261-2_19.

本文引用的文献

1
Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.
Circulation. 2004 Aug 24;110(8):962-8. doi: 10.1161/01.CIR.0000140667.37070.07. Epub 2004 Aug 9.
2
Engineered heart tissue for regeneration of diseased hearts.
Biomaterials. 2004 Apr;25(9):1639-47. doi: 10.1016/s0142-9612(03)00521-0.
3
Fabrication of novel biomaterials through molecular self-assembly.
Nat Biotechnol. 2003 Oct;21(10):1171-8. doi: 10.1038/nbt874.
4
Adult cardiac stem cells are multipotent and support myocardial regeneration.
Cell. 2003 Sep 19;114(6):763-76. doi: 10.1016/s0092-8674(03)00687-1.
6
Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.
Circulation. 2003 Apr 15;107(14):1912-6. doi: 10.1161/01.CIR.0000064899.53876.A3. Epub 2003 Mar 31.
7
Tissue engineering strategies for in vivo neovascularisation.
Expert Opin Biol Ther. 2002 Dec;2(8):805-18. doi: 10.1517/14712598.2.8.805.
8
The post-natal heart contains a myocardial stem cell population.
FEBS Lett. 2002 Oct 23;530(1-3):239-43. doi: 10.1016/s0014-5793(02)03477-4.
9
Tissue engineering of a differentiated cardiac muscle construct.
Circ Res. 2002 Feb 8;90(2):223-30. doi: 10.1161/hh0202.103644.
10
A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
Drug Deliv. 2001 Oct-Dec;8(4):215-22. doi: 10.1080/107175401317245895.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验